TLR 7/8: Covaxin’s Key molecule developed by Indian lab 

TLR 7/8: Covaxin’s Key molecule developed by Indian lab 

Part of: GS Prelims and GS- III – Sci & Tech; Achievements of Indians

In news:

• The Indian Institute of Chemical Technology (IICT), a Council for Scientific and Industrial Research (CSIR) lab helped in the development of key molecule for COVAXIN. 

Key takeaways 

• Covaxin is the indigenous vaccine developed by the Bharat Biotech International Limited.
• It is a highly purified, whole virion, inactivated SARS-Cov-2.
• It has been formulated with ‘Algel-IMDG’, which contains chemically absorbed TLR7/8 as an adjuvant onto aluminium hydroxide gel to generate the requisite type of immune responses without damaging the body.

Related articles:

Towards an effective vaccination distribution policy